Report me for selling fake medicine? Why are you crying when your illness relapses?

……

Chen Xuan created two innovative drugs at the same time!

And both drugs were successful.

Even directly enter the clinical trial stage.

Is this still a miracle?

This is a fucking miracle.

In contrast, other pharmaceutical companies instantly became useless.

Especially some domestic pharmaceutical companies, they dare not show up at this moment, for fear of being targeted by netizens.

These pharmaceutical companies are making a lot of money, but they have made almost no contribution to the field of innovative drugs.

Even a few leading pharmaceutical companies mostly focus on generic drugs or traditional Chinese medicine prescriptions, with no real innovation at all.

The investment in innovative drugs is almost negligible and far less than the marketing costs.

Compared with Antai Pharmaceutical Group, which often comes up with new innovative results, these pharmaceutical companies that have made no achievements seem even more useless.

Therefore, with Antai Pharmaceutical Group at its peak, these pharmaceutical companies naturally dared not speak out for fear of being noticed.

Rather than being attacked by countless netizens, it is better to pretend to be an ostrich.

……

"Two new drugs?"

"One of them is a special medicine for treating cancer?"

"What's going on with his brain? Is it really different from ours?"

After learning about this, Anna couldn't help but look a little confused.

It is already remarkable that we can develop innovative drugs.

As a result, the innovative drugs developed by Chen Xuan are all effective drugs for treating cancer, which are drugs that major pharmaceutical giants cannot conquer.

But in his case, they were born one after another, as if they were ordinary medicines.

Not to mention independent innovation, even generic drugs cannot be so efficient.

As a pharmaceutical company practitioner, Anna is naturally aware of the difficulty involved, which is why she feels so emotional.

"Except for a specific drug that cures cancer."

"What field is the other special medicine in?"

"However, just one cancer-specific drug alone is likely enough to put those pharmaceutical companies in a difficult position."

While full of curiosity, Anna was also gloating.

Chen Xuan’s innovative drugs are basically focused on cancer and have not yet involved other fields.

Coincidentally, anti-cancer drugs have always been Novartis' weak point, making it difficult for it to compete with Aetna Pharmaceutical Group.

Now Novartis' most important anti-cancer drug is a specific drug for liver cancer.

But Anna can confirm that the new drug developed by Chen Xuan is basically impossible to be a specific drug for liver cancer.

Among the world's top ten pharmaceutical giants, several of them focus on oncology drugs, which is their main source of revenue and their most important business.

If the anti-cancer drugs developed by Chen Xuan happen to collide with the business of these giants, the scene might be very exciting.

Therefore, Anna felt that these pharmaceutical companies were probably very anxious at this time, and must be asking various sources for information about Antai Pharmaceutical Group's new drugs, for fear of being in conflict with Antai Pharmaceutical Group.

Even though they are all giants, who dares not to be anxious when facing an opponent like Chen Xuan?

After all, the new drug he developed was so effective that it completely outperformed similar drugs. The gap was too huge.

Under such circumstances, the new drug he had recently developed would naturally make his opponents extremely nervous.

I'm afraid many pharmaceutical companies are praying.

I hope the new drugs developed by Chen Xuan will not collide with their main business. If they are unlucky enough and it does, their good days may not last long.

And the fact is just as Anna thought.

Many international pharmaceutical giants are taking action and using various means to find out about Chen Xuan's new drug.

In addition to exploring new drug types, they are also looking for ways to acquire his new drug formulas and are already comparing and evaluating prices.

People both at home and abroad are inquiring about Antai Pharmaceutical and are curious about these two new drugs.

However, this does not affect the normal operation of Antai Pharmaceutical Group.

The group has also been promoting clinical trials of new drugs and has not been hindered by this.

The days pass by one by one.

It seems like a flash of lightning.

One day, Antai Pharmaceutical Group suddenly announced a new drug launch conference.

As soon as this news came out, everyone was shocked.

In order to enter the press conference, countless media reporters tried their best to get an invitation.

This kind of press conference is not open to just anyone. Without an invitation, you can only wait outside in the cold.

Even CCTV sent reporters to conduct a live interview, which was extremely exciting.

Of course, with Antai Pharmaceutical Group's current achievements, it fully deserves such treatment.

"Hello everyone! I'm Luo Shiyun! Executive President of Antai Pharmaceutical Group."

"Today's new drug launch conference will be hosted by me."

"Of course, our group's chairman and chief research and development officer will also introduce the new drug to you later."

After Luo Shiyun came to the stage, she first gave a brief introduction.

After livening up the atmosphere, she went straight to the point.

"First of all, our new drug has now entered the second phase of clinical trials."

"The results of the previous phase I clinical trial exceeded expectations, and the patients' conditions improved."

"So, after considering that the drug's safety is guaranteed, we entered the second phase of clinical trials, hoping that this drug can be launched on the market as soon as possible so that more patients can benefit."

Afterwards, Luo Shiyun emphasized the specific drug for lung cancer, which is also the focus of Antai Pharmaceutical Group.

In the future, Antai Pharmaceutical Group will use lung cancer specific drugs as its main profit point, and of course it will pay more attention to it.

As for other drugs, even if clinical trials begin, they will not be available on the market so quickly.

After lung cancer-specific drugs pass phase II and III clinical trials, they can be approved for marketing.

Whether the funds can be recovered depends entirely on the performance of the specific drug for lung cancer.

If the first drug performs well after it is launched on the market, the road ahead will be easier.

"Antai Pharmaceutical Group is so efficient that they started the second phase of clinical trials so quickly."

"This is more than just a Phase II clinical trial. I heard that Phase III clinical trials have already begun preparations and may be launched at any time."

"Hiss, is Antai Pharmaceutical Group trying to break the record for the fastest clinical trial of a new drug and successfully obtain approval for marketing in the fastest time?"

"It's certainly fast, but the quality is not guaranteed. Slow work makes fine work is an eternal truth."

"What are you talking about? Can't it be quicker? This kind of life-saving medicine must be delivered as soon as possible!"

"Yes, we can wait slowly, but can those patients wait slowly?"

"Yes, I believe in the technology and conscience of Antai Pharmaceutical Group. If Chen Xuan thinks it's okay, then there will definitely be no problem."

"Actually, I'd rather be interested in new drugs. Lung cancer drugs are old news, but new drugs are the real sweetie."

No one was surprised by the news that Luo Shiyun said.

The main reason is that this news has already spread everywhere and everyone has known about it for a long time.

What everyone is concerned about now is what kind of new drug Chen Xuan has recently developed?

……